Ral (Ras-like) GTPases play an important role in the control of cell proliferation and have been implicated in Ras-mediated tumorigenicity. Only recently, variants in RALA were described as a cause of intellectual disability and developmental delay, indicating the importance of this pathway in neuropediatric diseases. Here, we report the identification of biallelic variants in RALGAPA1 (also termed TULIP1; encoding Ral GTPase activating protein catalytic alpha subunit 1) in four unrelated families with profound neurodevelopmental disability, muscular hypotonia, feeding difficulties, recurrent febrile episodes, and infantile spasms. RalGAPA1 protein was absent in fibroblasts derived from affected individuals suggesting a loss of function effect of the RALGAPA1 variants. As a consequence, RalA activity was increased in these cell lines, which is in keeping with the idea that RalGAPA1 deficiency causes constitutive activation of RalA. Additionally, protein levels of RalGAPB, a scaffolding subunit of the RalGAP complex, were dramatically downregulated, indicating a dysfunctional RalGAP complex. Our findings indicate that dysregulation of the RalA-pathway has an important impact on neuronal function and brain development. In view of the partially overlapping phenotype between RALA- and RALGAPA1-associated diseases, it appears likely that dysregulation of the RalA signaling pathway leads to a distinct group of genetic syndromes, which we suggest to be named RALopathies.